PT1007085E - Utilizacao da hormona de crescimento em composicoes para o tratamento da resistencia a insulina no coracao - Google Patents
Utilizacao da hormona de crescimento em composicoes para o tratamento da resistencia a insulina no coracaoInfo
- Publication number
- PT1007085E PT1007085E PT98932685T PT98932685T PT1007085E PT 1007085 E PT1007085 E PT 1007085E PT 98932685 T PT98932685 T PT 98932685T PT 98932685 T PT98932685 T PT 98932685T PT 1007085 E PT1007085 E PT 1007085E
- Authority
- PT
- Portugal
- Prior art keywords
- heart
- growth hormone
- insulin resistance
- compositions
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH] (Somatotropin)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9702595A SE9702595D0 (sv) | 1997-07-04 | 1997-07-04 | new therapeutic use |
SE9802023A SE9802023D0 (sv) | 1998-06-08 | 1998-06-08 | New therapeutic use |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1007085E true PT1007085E (pt) | 2002-05-31 |
Family
ID=26663028
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT98932685T PT1007085E (pt) | 1997-07-04 | 1998-06-26 | Utilizacao da hormona de crescimento em composicoes para o tratamento da resistencia a insulina no coracao |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1007085B1 (pt) |
JP (1) | JP2002511876A (pt) |
AT (1) | ATE209042T1 (pt) |
AU (1) | AU737065B2 (pt) |
CA (1) | CA2294824A1 (pt) |
DE (1) | DE69803298T2 (pt) |
DK (1) | DK1007085T3 (pt) |
ES (1) | ES2168772T3 (pt) |
NO (1) | NO20000007L (pt) |
NZ (1) | NZ501961A (pt) |
PT (1) | PT1007085E (pt) |
WO (1) | WO1999001151A1 (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU4669499A (en) * | 1998-06-08 | 1999-12-30 | Pharmacia & Upjohn Ab | New therapeutic use of pkb (proteine kinase b) enhancers |
SE9901634D0 (sv) * | 1999-05-05 | 1999-05-05 | Sahltech Ab | Treatment of myocardial infarction with a substance related to the growth hormone axis |
SE0000837D0 (sv) * | 2000-03-13 | 2000-03-13 | Pharmacia & Upjohn Ab | New use |
AU2006200127B2 (en) * | 2000-03-13 | 2007-10-25 | Pfizer Inc. | Use of growth hormone in low dose |
CA2661521C (en) * | 2006-08-31 | 2016-04-12 | Novartis Ag | Pharmaceutical compositions comprising hgh for oral delivery |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5935924A (en) * | 1994-04-15 | 1999-08-10 | Genentech, Inc. | Treatment of congestive heart failure |
KR960703275A (ko) * | 1994-04-18 | 1996-06-19 | 쟈끄 위베르 가이 | 전자메모리장치(electronic memory device) |
EP0766966A3 (en) * | 1995-09-08 | 2001-02-28 | Eli Lilly And Company | Method of treating insulin resistance |
SE9601397D0 (sv) * | 1996-04-12 | 1996-04-12 | Pharmacia Ab | Use of growth hormone |
-
1998
- 1998-06-26 AU AU82506/98A patent/AU737065B2/en not_active Ceased
- 1998-06-26 CA CA002294824A patent/CA2294824A1/en not_active Abandoned
- 1998-06-26 WO PCT/SE1998/001261 patent/WO1999001151A1/en active IP Right Grant
- 1998-06-26 AT AT98932685T patent/ATE209042T1/de not_active IP Right Cessation
- 1998-06-26 NZ NZ501961A patent/NZ501961A/en unknown
- 1998-06-26 DE DE69803298T patent/DE69803298T2/de not_active Expired - Fee Related
- 1998-06-26 JP JP50702099A patent/JP2002511876A/ja not_active Withdrawn
- 1998-06-26 PT PT98932685T patent/PT1007085E/pt unknown
- 1998-06-26 EP EP98932685A patent/EP1007085B1/en not_active Expired - Lifetime
- 1998-06-26 ES ES98932685T patent/ES2168772T3/es not_active Expired - Lifetime
- 1998-06-26 DK DK98932685T patent/DK1007085T3/da active
-
2000
- 2000-01-03 NO NO20000007A patent/NO20000007L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU737065B2 (en) | 2001-08-09 |
NO20000007D0 (no) | 2000-01-03 |
NZ501961A (en) | 2001-11-30 |
AU8250698A (en) | 1999-01-25 |
NO20000007L (no) | 2000-03-06 |
EP1007085B1 (en) | 2001-11-21 |
EP1007085A1 (en) | 2000-06-14 |
ATE209042T1 (de) | 2001-12-15 |
ES2168772T3 (es) | 2002-06-16 |
DK1007085T3 (da) | 2002-05-13 |
CA2294824A1 (en) | 1999-01-14 |
DE69803298T2 (de) | 2002-08-08 |
DE69803298D1 (de) | 2002-02-21 |
WO1999001151A1 (en) | 1999-01-14 |
JP2002511876A (ja) | 2002-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69533112T2 (de) | Verwendung von flavolignanen zur herstellung von medikamenten mit antiproliferativer aktivität in gebärmutter,brust,eierstöcken | |
NZ504026A (en) | Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C | |
CA2334267A1 (en) | Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis c | |
DE60023476D1 (de) | Kombination von doctaxel und rhumab her2 zür krebsbehandlung | |
WO2005027842A8 (en) | Combinations of drugs for the treatment of neoplasms | |
MY164077A (en) | Compositions and uses of et743 for treating cancer | |
ES2010561A6 (es) | Procedimiento para preparar una composicion farmaceutica a base de un analogo de somatostatina. | |
DE69400353T2 (de) | Schlankmachende Zusammensetzung | |
BR9500436A (pt) | Produtos uso de um g-csf uso de uma proteína tnf ligante processo para o tratamento e/ou prevenção do choque séptico | |
PT1007085E (pt) | Utilizacao da hormona de crescimento em composicoes para o tratamento da resistencia a insulina no coracao | |
WO1999056666A8 (en) | The treatment of sexual dysfunction in certain patient groups | |
ATE311897T1 (de) | Behandlung von multiplersklerose mit einer kombination von interferon und wachstumshormone | |
GR3032224T3 (en) | Therapeutic agent for threatened abortion. | |
EP0821969A3 (en) | Medicinal Composition comprising TCF-II | |
ATE359808T1 (de) | Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma | |
ATE345805T1 (de) | Calciumtrifluoracetat mit zytotoxischer wirkung | |
WO1999013894A3 (en) | Use of ifn-alpha and amantadine for the treatment of chronic hepatitis c | |
DE60125377D1 (de) | Behandlung von hepatitis c mit thymosin, interferon und ribavirin | |
MD1469G2 (ro) | Metodă de tratament al şocului combustional | |
ATE332704T1 (de) | Behandlung von hepatitis c mit thymosin und pegyliertem interferon | |
UA43800A (uk) | Спосіб лікування перфоративної виразки дванадцятипалої кишки |